As a leading full service CRO, PSI provides the services required to support global clinical trials, offering in-depth therapeutic experience across Phase I-IV clinical programs. We provide you with the expertise that is needed to conduct your clinical trial, whether it is a Phase I study, proof-of-concept or rescuing a pivotal study where enrollment is behind schedule; our goal is to complete your study on time!
For respiratory disease studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience and relationships with investigators to manage and support their efforts to meet enrollment goals.
PSI has successfully performed Phase II/III studies in the following respiratory indications:
- Asthma – Adult & Pediatric
- Ventilator Acquired Pneumonia
- Lung Cancers
|
- Community Acquired Pneumonia
- Hospital Acquired Pneumonia
|
- COPD
- Acute Bronchitis
- ARDS
|
PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including pulmonologists, critical care specialists, and neonatologists. This provides us with directly relevant experience in managing respiratory clinical trials.
Case Study Examples: Asthma Clinical Trial, HAP VAP Clinical Trial, Lung Cancer Clinical Trial
